Clinical Trial Update: Feasible Insulin Algorithm for Glycemic Control in Patients With Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating a feasible insulin-based algorithm for glycemic control in patients with acute coronary syndrome has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Insulin (insulin)

Snippet

Sponsor: Universidade Positivo | Conditions: Acute Coronary Syndrome | Phase 4 | Status: SUSPENDED